Announcement on Cancellation of Account for Raised Funds
Filed with SSE · · 3 pages · Chinese
Zhejiang Huahai Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Huahai Pharmaceutical
- Indicative Announcement on Convening the 2025 Annual General Meeting
- Announcement on Outline of Open Day for Investors
- Announcement on Changing Independent Directors and Adjusting Members of Special Committees of Board of Directors
- Announcement on Disclosure of the 2025 Annual Report by the Holding Subsidiary, Changxing Pharmaceutical Co., Ltd.
- Announcement on the Return of Raised Funds
Later from Zhejiang Huahai Pharmaceutical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Obtaining Approval for Drug Clinical Trials by Subsidiary
- Announcement on Release of Pledge and Re-pledge of Some Shares of Shareholders
- Indicative Announcement on Suspending Conversion of "Huahai Convertible Bonds" When Implementing Dividend Distribution for 2025
Follow Zhejiang Huahai Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Huahai Pharmaceutical